FDA Adverse Event
Injury
Summary report: N
T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY
MDR report key: 9330372
·
Received November 15, 2019
Report
- Report Number
- 3013756811-2019-79271
- Event Type
- Injury
- Date Received
- November 15, 2019
- Date of Event
- October 25, 2019
- Report Date
- November 15, 2019
- Manufacturer
- TANDEM DIABETES CARE
- Product Code
- OZO
- UDI-DI
- 00853052007325
- PMA / PMN Number
- P180008
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- FL, US
- Reporter Occupation
- OTHER
Narratives
Additional Manufacturer Narrative · 1
NO PRODUCT WAS RETURNED FOR EVALUATION. SHOULD NEW RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
Description of Event or Problem · 1
IT WAS REPORTED THAT THE CUSTOMER EXPERIENCED BLOOD GLUCOSE (BG) LEVELS BETWEEN 233-480 MG/DL WITH KETONE LEVEL IDENTIFIED BY HEALTHCARE PROVIDER AS BEING DANGEROUS. CAUSE OF ELEVATED BG WAS UNKNOWN. CUSTOMER CHANGED SUPPLIES AND WENT TO THE EMERGENCY ROOM (ER) AND AN INSULIN DRIP WAS ADMINISTERED. CUSTOMER WAS SUBSEQUENTLY ADMITTED TO THE INTENSIVE CARE UNIT. AT THE TIME OF THE REPORT, CUSTOMER STATED THAT THEY WOULD BE DISCHARGED ON (B)(6) 2019; HOWEVER, CUSTOMER DID NOT RESPOND TO FOLLOW UP ATTEMPTS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1124473 | T:SLIM X2 INSULIN PUMP WITH BASAL-IQ TECHNOLOGY | AUTOMATED INSULIN DOSING, THRESHOLD SUSPEND | OZO | TANDEM DIABETES CARE | 1000096 | 00853052007325 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 24 YR | Hospitalization| L| R | INSULIN: NOVOLOG / NOVORAPID |